常滿控股(08523.HK)中期淨虧3613.6萬港元 繼續停牌
格隆匯12月20日丨常滿控股(08523.HK)發佈公吿,截至2022年9月30日止六個月,集團的收益同比減少61.1%至約5970萬港元。收益減少主要是由於三個主要項目於期內經已竣工,而有關項目的收益於上一期間經已入賬,因此並無於回顧期間內反映。
報吿期內,公司擁有人應占期內虧損3613.6萬港元,上年同期公司擁有人應占期內虧損318.7萬港元,基本每股虧損9.03港仙。公司股份已按照GEM上市規則第17.49B條的規定自2022年8月15日上午九時正起暫停在聯交所買賣,並將繼續停牌直至另行通知。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.